AdAlta (ASX:1AD) FCF Yield % : -44.58 (As of May. 25, 2024)

View and export this data going back to 2016. Start your Free Trial

What is AdAlta FCF Yield %?

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, AdAlta's Trailing 12-Month Free Cash Flow is A$-6.18 Mil, and Market Cap is A$13.86 Mil. Therefore, AdAlta's FCF Yield % for today is -44.58%.

The historical rank and industry rank for AdAlta's FCF Yield % or its related term are showing as below:

ASX:1AD' s FCF Yield % Range Over the Past 10 Years
Min: -86.92 Med: -31.75 Max: -14.59
Current: -44.58

During the past 7 years, the highest FCF Yield % of AdAlta was -14.59%. The lowest was -86.92%. And the median was -31.75%.

ASX:1AD's FCF Yield % is ranked worse than
73.6% of 1553 companies
in the Biotechnology industry
Industry Median: -14.53 vs ASX:1AD: -44.58

AdAlta's FCF Margin % for the quarter that ended in Dec. 2023 was 0.00%.

AdAlta FCF Yield % Historical Data

The historical data trend for AdAlta's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

AdAlta FCF Yield % Chart

AdAlta Annual Data

Trend

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

FCF Yield %

Get a 7-Day Free Trial

-24.85

-42.27

-15.61

-24.25

-58.34

AdAlta Semi-Annual Data
	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
FCF Yield %	Get a 7-Day Free Trial										-7.13	-38.51	-20.49	-86.68	-37.50

Competitive Comparison of AdAlta's FCF Yield %

For the Biotechnology subindustry, AdAlta's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

AdAlta's FCF Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, AdAlta's FCF Yield % distribution charts can be found below:

* The bar in red indicates where AdAlta's FCF Yield % falls into.

AdAlta FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

AdAlta's FCF Yield % for the fiscal year that ended in Jun. 2023 is calculated as

FCF Yield %	=	Free Cash Flow	/	Market Cap
	=	-5.134	/	8.80032
	=	-58.34%

AdAlta's annualized FCF Yield % for the quarter that ended in Dec. 2023 is calculated as

FCF Yield %	=	Free Cash Flow	*	Annualized Factor	/	Market Cap
	=	-2.366	*	2	/	12.619296
	=	-37.50%

AdAlta FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.

AdAlta FCF Yield % Related Terms

Thank you for viewing the detailed overview of AdAlta's FCF Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.

AdAlta (ASX:1AD) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » AdAlta Ltd (ASX:1AD) » Definitions » FCF Yield %

Comparable Companies

Traded in Other Exchanges

N/A

Address

2 Park Drive, Unit 15, Bundoora, VIC, AUS, 3083

Website

https://www.adalta.com.au

AdAlta Ltd is engaged in drug discovery and development company developing protein therapeutics, known as i-bodies, for treating a wide range of human diseases. The i-body candidate, AD-214, is being developed for the treatment of idiopathic pulmonary fibrosis and other fibrotic diseases, for which current therapies are sub-optimal. Its pipeline includes Fibrosis, and CAR-T cancer therapeutics.

AdAlta (ASX:1AD) Headlines

No Headlines